Wedoany.com Report-Apr. 12, RWE, a German energy company, and Sanofi, a French pharmaceutical firm, have entered into a 20-year wind power purchase agreement (PPA). Through this arrangement, RWE will provide Sanofi with 21GWh of renewable electricity each year from the Chemin de Châlons 1 wind farm, located in Marne, France. The agreement, which took effect earlier this year, supports Sanofi’s goals for transitioning to sustainable energy sources.

The long-term contract underscores a significant commitment between the two companies. Olaf Lubenow, RWE’s head of commodity solutions for the UK, north, and south Europe, stated: “A 20-year contract represents a long-term commitment and is a testament to the mutual trust between the signatories. This PPA highlights the relevance and competitiveness of renewable energy, particularly onshore wind, in supporting the growth and decarbonisation of French industry without relying on state subsidies.” The deal showcases the value of wind power in driving industrial sustainability.

The Chemin de Châlons 1 wind farm will serve as a reliable source of green energy for Sanofi, enabling the company to reduce its carbon footprint over the next two decades. This partnership reflects a growing trend among businesses to secure renewable energy directly from producers, ensuring both environmental benefits and energy stability. For RWE, the agreement strengthens its position as a key supplier of clean energy in Europe.

By locking in this 20-year supply, Sanofi gains a steady flow of electricity to power its operations, aligning with broader efforts to decarbonize French industry. The PPA demonstrates how renewable sources, like onshore wind, can meet the needs of large-scale enterprises efficiently and competitively, contributing to a more sustainable future without external financial support.